Format

Send to

Choose Destination
Apoptosis. 2017 Nov;22(11):1362-1379. doi: 10.1007/s10495-017-1407-x.

Modulation of adenylate cyclase signaling in association with MKK3/6 stabilization under combination of SAC and berberine to reduce HepG2 cell survivability.

Author information

1
Molecular Biology and Tissue Culture Laboratory, Post Graduate Department of Zoology, Vidyasagar College, Kolkata, 700006, India.
2
Cyto-genetics Laboratory, Department of Zoology, Rammohon College, 102/1, Raja Rammohan Sarani, Kolkata, 700009, India.
3
Cyto-genetics Laboratory, Department of Zoology, Kanchrapara College, North 24 PGS, Kanchrapara, 743145, India.
4
Molecular Biology and Tissue Culture Laboratory, Post Graduate Department of Zoology, Vidyasagar College, Kolkata, 700006, India. sadhukhan.g.c@gmail.com.

Abstract

Cancer cells often have faulty apoptotic pathways resulting in sustenance of survivability, tumour metastasis and resistance to anticancer drugs. Alternate strategies are sought to improve therapeutic efficacy and therefore HepG2 cells were treated with S-allyl-cysteine (SAC) and berberine (BER) to analyze their mechanistic impact upon necroptosis along with its interacting relationship to apoptosis. In the present study we observed that SAC and BER exposure reduced NFκβ nuclear translocation through adenylate cyclase-cAMP-protein kinaseA axis and eventually evaded c-FLIP inhibition. Effective RIP1 k63-polyubiquitination and persistent MKK3/MKK6 expression during drug treatment potentiated caspase8 activity via p53-DISC conformation. Resultant tBid associated lysosomal protease mediated AIF truncation induced DNA fragmentation and persuaded effector caspase mediated scramblase activation resulting induction of necroptosis in parallel to apoptotic events. SAC+BER effectively reduced Rb-phosphorylation resulting insignificant nuclear E2F presence led to ending of cell proliferation. Therefore necroptosis augmented the drug response and may be targeted alongside cell proliferation inhibition in formation of efficient therapeutics against liver cancer.

KEYWORDS:

Adenylate cyclase; CathepsinB; RIP1-K63-polyubiquitination; Rb phosphorylation; tAIF

PMID:
28836036
DOI:
10.1007/s10495-017-1407-x
[Indexed for MEDLINE]

MeSH terms, Substances

MeSH terms

Substances

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center